Showing results (1091-1100 of 5,983) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|October 31, 2013
BAY 80-6946 is a highly selective intravenous PI3K inhibitor with potent p110α and p110δ activities in tumor cell lines and xenograft modelsNingshu Liu, Bruce R Rowley, Cathy O Bull, et al.
Molecular Cancer Therapeutics|August 28, 2013
PARP1 is overexpressed in nasopharyngeal carcinoma and its inhibition enhances radiotherapyJeremy P H Chow, Wing Yu Man, Mao Mao, et al.
Molecular Cancer Therapeutics|August 22, 2013
Molecular radiotherapy using cleavable radioimmunoconjugates that target EGFR and γH2AXBart Cornelissen, Andrew Waller, Sarah Able, et al.
Molecular Cancer Therapeutics|August 14, 2013
Overcoming platinum resistance in preclinical models of ovarian cancer using the neddylation inhibitor MLN4924Amir A Jazaeri, Etsuko Shibata, Jonghoon Park, et al.
Molecular Cancer Therapeutics|August 14, 2013
A urokinase receptor-derived peptide inhibiting VEGF-dependent directional migration and vascular sproutingKatia Bifulco, Immacolata Longanesi-Cattani, Eleonora Liguori, et al.
Molecular Cancer Therapeutics|August 14, 2013
Novel inhibitors of cyclin-dependent kinases combat hepatocellular carcinoma without inducing chemoresistanceChristine Haider, Markus Grubinger, Eva Řezníčková, et al.
Molecular Cancer Therapeutics|September 11, 2013
A novel small-molecule inhibitor of mcl-1 blocks pancreatic cancer growth in vitro and in vivoFardokht Abulwerdi, Chenzhong Liao, Meilan Liu, et al.
Molecular Cancer Therapeutics|September 13, 2013
Axl mediates acquired resistance of head and neck cancer cells to the epidermal growth factor receptor inhibitor erlotinibKeith M Giles, Felicity C Kalinowski, Patrick A Candy, et al.
Molecular Cancer Therapeutics|September 14, 2013
The cannabinoid WIN 55,212-2 decreases specificity protein transcription factors and the oncogenic cap protein eIF4E in colon cancer cellsSandeep Sreevalsan, Stephen Safe
Molecular Cancer Therapeutics|September 14, 2013
PRIMA-1Met/APR-246 displays high antitumor activity in multiple myeloma by induction of p73 and NoxaManujendra N Saha, Hua Jiang, Yijun Yang, et al.
Pageof 599